Jun 02, 2020
ReddyPort receives CE Mark Approval for ReddyPort(TM) Elbow Non-Invasive Ventilation product
Apr 14, 2020
COVID-19 ARDS Patients Added to Healios ONE-BRIDGE Study
Apr 01, 2020
Mallinckrodt and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of High-Dose Inhaled Nitric Oxide Therapy for COVID-19 Infection and Associated Lung Complications
Mar 26, 2020
Regarding HLCM051 for Acute Respiratory Distress Syndrome (ARDS) Caused by COVID -19
Mar 24, 2020
Partner Therapeutics Announces Initiation of Clinical Trial to Evaluate Leukine® in Patients with COVID-19 Associated Respiratory Illness
Mar 13, 2020
ADVISORY: Online Media Briefing About Acute Respiratory Distress Syndrome and COVID-19 Set for Monday with ARDS Foundation and Dr. Michael Matthay
Mar 12, 2020
Mallinckrodt Evaluates the Potential Role for Inhaled Nitric Oxide to Treat COVID-19 Associated Lung Complications, Engages with Scientific, Governmental and Regulatory Agencies
Oct 21, 2019
Mallinckrodt Raises Awareness of Critical Role Respiratory Therapists Play in Patient Care During Respiratory Care Week
Oct 17, 2019
Acute Respiratory Distress Syndrome (ARDS) Market To Reach USD 934.8 Million By 2026 | Reports And Data
Mar 22, 2018
Respiratory Motion, Inc. is excited to announce FDA clearance for use of the ExSpiron(TM) 1Xi Minute Ventilation Monitor in Pediatric Patients
Jan 17, 2018
Extracorporeal Membrane Oxygenation Machine Market to Reach US$487.40 Mn by 2025, Globally: Transparency Market Research
Nov 15, 2017
Respiratory Motion, Inc. and Corestone Biosciences (Beijing) Co., Ltd., have established a Joint Venture Company to deliver monitoring solutions to Chinese healthcare market and the globe
Oct 31, 2017
Respiratory Compromise Institute Highlights Dangers and Growing Incidence of Respiratory Compromise - a Potentially Deadly Condition - at CHEST 2017
Jun 26, 2017
Acute Respiratory Distress Syndrome (ARDS) Forecast in 11 Major Markets 2017-2027 - Research and Markets